IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS - ANVISA Registration 80020690461

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80020690461 and manufactured by BIO-RAD LABORATORIOS BRASIL LTDA.. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Jun 30, 2034.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including IMMUCOR, INC, MEDION DIAGNOSTICS GRIFOLS AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80020690461
Registration Details
ANVISA Registration Number: 80020690461
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80020690461

25351111703202570

03188198000177

Company Information

Brazil
PT: BRASIL

Dates and Status

Jul 14, 2025

30/06/2034

09/18/2025 19:00:01